세포 분리 기술 시장 규모, 점유율, 동향 및 예측 : 제품별, 세포 유형별, 기술별, 용도별, 최종 사용자별, 지역별(2026-2034년)

The global cell separation technologies market size was valued at USD 13.4 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 38.3 Billion by 2034, exhibiting a CAGR of 12.01% during 2026-2034. North America currently dominates the market, holding a significant market share of over 40.0% in 2025. The rising adoption of cell separation technologies across the pharmaceutical and biotechnology sectors, the growing demand for personalized medicine, and ongoing technological advancements in the industry represent some of the key factors driving the market.

Cell separation technologies, or cell isolation technologies, refer to a range of methods and techniques used to isolate specific cells from a heterogeneous mixture of cells. Some of the standard techniques include microfluidic cell sorting, fluorescence-activated cell sorting (FACS), immunogenicity cell isolation, magnetic-activated cell sorting (MACS), and density gradient configuration. Cell separation technologies help isolate rare tumor cells or stem cells for further analysis and therapeutic purposes. As a result, they are used across the healthcare and biotechnology industries for research, clinical, and industrial applications, such as disease diagnosis, drug discovery, and bioprocessing. In addition to this, cell separation technologies are essential for studying cellular heterogeneity to understand disease mechanisms and develop personalized medicines.

Cell Separation Technologies Market Trends:

The increasing use of cell separation technologies across the pharmaceutical industry to enhance drug discovery and development procedures represents the primary factor driving the market growth. In line with this, the growing prevalence of numerous chronic and infectious diseases, such as cancer, acquired immune deficiency syndrome (AIDS), and cystic fibrosis, is propelling the market growth. Moreover, the increasing demand for personalized and regenerative medicines is fueling the need for highly specific cell separation technologies that can isolate specific cell types for targeted therapy. Besides this, the widespread utilization of cell separation technologies in manufacturing vaccines for various diseases, including human papillomavirus (HPV), influenza, and rotavirus, is creating a favorable outlook for the market. In addition to this, extensive investments in research and development (R&D) initiatives in the flourishing biotechnology sector for developing novel cell-based treatments and therapies are contributing to the market growth. Concurrent with this, an intensive focus on stem cell research, the surging demand for in vitro diagnostics, and the implementation of numerous favorable initiatives undertaken by governments of various countries to improve healthcare infrastructure are aiding in market expansion. Furthermore, ongoing technological advancements in cell separation technologies, such as microfluidics, lab-on-a-chip, and microarray technologies, are presenting remunerative growth opportunities for the market. Furthermore, the advent of advanced isolation tools that allows continuous examination of nucleic acids, chromatin, proteins, and other complex cells is acting as another significant growth-inducing factor.

Market Segmentation:

This report provides an analysis of the key trends in each segment of the global cell separation technologies market, along with forecasts at the global, regional, and country levels from 2026-2034. The market has been categorized based on product, cell type, technology, application, and end user.

Product Insights:

• Instruments
• Consumables

Cell Type Insights:

• Human Cells
• Animal Cells

Technology Insights:

• Centrifugation-based Cell Separation
• Surface marker-based Cell Separation
• Filtration-based Cell Separation

Application Insights:

• Oncology Research
• Neuroscience Research
• Stem Cell Research
• Microbiology
• Immunology Research
• Others

End User Insights:

• Research Laboratories and Institute
• Biotechnology and Biopharmaceutical Companies
• Cell Banks

Regional Insights:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cell separation technologies. Some of the factors driving the North America cell separation technologies market included the bolstering growth of the pharmaceutical industry, the rising demand for personalized medicines, and the ongoing advancements in isolation tools.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global cell separation technologies market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Akadeum Life Sciences, Alfa Laval AB, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Corning Incorporated, Merck KGaA, Miltenyi Biotec Inc., PerkinElmer Inc., pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG, Stemcell Technologies Inc., Terumo Corporation and Thermo Fisher Scientific Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

1. How big is the cell separation technologies market?

2. What is the future outlook of cell separation technologies market?

3. What are the key factors driving the cell separation technologies market?

4. Which region accounts for the largest cell separation technologies market share?

5. Which are the leading companies in the global cell separation technologies market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Cell Separation Technologies Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Instruments
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Consumables
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Cell Type

• 7.1 Human Cells
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Animal Cells
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Technology

• 8.1 Centrifugation-based Cell Separation
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Surface marker-based Cell Separation
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Filtration-based Cell Separation
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Application

• 9.1 Oncology Research
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Neuroscience Research
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Stem Cell Research
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Microbiology
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Immunology Research
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast
• 9.6 Others
  • 9.6.1 Market Trends
  • 9.6.2 Market Forecast

10 Market Breakup by End User

• 10.1 Research Laboratories and Institute
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Biotechnology and Biopharmaceutical Companies
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Cell Banks
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast

11 Market Breakup by Region

• 11.1 North America
  • 11.1.1 United States
    • 11.1.1.1 Market Trends
    • 11.1.1.2 Market Forecast
  • 11.1.2 Canada
    • 11.1.2.1 Market Trends
    • 11.1.2.2 Market Forecast
• 11.2 Asia-Pacific
  • 11.2.1 China
    • 11.2.1.1 Market Trends
    • 11.2.1.2 Market Forecast
  • 11.2.2 Japan
    • 11.2.2.1 Market Trends
    • 11.2.2.2 Market Forecast
  • 11.2.3 India
    • 11.2.3.1 Market Trends
    • 11.2.3.2 Market Forecast
  • 11.2.4 South Korea
    • 11.2.4.1 Market Trends
    • 11.2.4.2 Market Forecast
  • 11.2.5 Australia
    • 11.2.5.1 Market Trends
    • 11.2.5.2 Market Forecast
  • 11.2.6 Indonesia
    • 11.2.6.1 Market Trends
    • 11.2.6.2 Market Forecast
  • 11.2.7 Others
    • 11.2.7.1 Market Trends
    • 11.2.7.2 Market Forecast
• 11.3 Europe
  • 11.3.1 Germany
    • 11.3.1.1 Market Trends
    • 11.3.1.2 Market Forecast
  • 11.3.2 France
    • 11.3.2.1 Market Trends
    • 11.3.2.2 Market Forecast
  • 11.3.3 United Kingdom
    • 11.3.3.1 Market Trends
    • 11.3.3.2 Market Forecast
  • 11.3.4 Italy
    • 11.3.4.1 Market Trends
    • 11.3.4.2 Market Forecast
  • 11.3.5 Spain
    • 11.3.5.1 Market Trends
    • 11.3.5.2 Market Forecast
  • 11.3.6 Russia
    • 11.3.6.1 Market Trends
    • 11.3.6.2 Market Forecast
  • 11.3.7 Others
    • 11.3.7.1 Market Trends
    • 11.3.7.2 Market Forecast
• 11.4 Latin America
  • 11.4.1 Brazil
    • 11.4.1.1 Market Trends
    • 11.4.1.2 Market Forecast
  • 11.4.2 Mexico
    • 11.4.2.1 Market Trends
    • 11.4.2.2 Market Forecast
  • 11.4.3 Others
    • 11.4.3.1 Market Trends
    • 11.4.3.2 Market Forecast
• 11.5 Middle East and Africa
  • 11.5.1 Market Trends
  • 11.5.2 Market Breakup by Country
  • 11.5.3 Market Forecast

12 SWOT Analysis

• 12.1 Overview
• 12.2 Strengths
• 12.3 Weaknesses
• 12.4 Opportunities
• 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

• 14.1 Overview
• 14.2 Bargaining Power of Buyers
• 14.3 Bargaining Power of Suppliers
• 14.4 Degree of Competition
• 14.5 Threat of New Entrants
• 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

• 16.1 Market Structure
• 16.2 Key Players
• 16.3 Profiles of Key Players
  • 16.3.1 Akadeum Life Sciences
    • 16.3.1.1 Company Overview
    • 16.3.1.2 Product Portfolio
  • 16.3.2 Alfa Laval AB
    • 16.3.2.1 Company Overview
    • 16.3.2.2 Product Portfolio
    • 16.3.2.3 Financials
    • 16.3.2.4 SWOT Analysis
  • 16.3.3 Becton, Dickinson and Company
    • 16.3.3.1 Company Overview
    • 16.3.3.2 Product Portfolio
    • 16.3.3.3 Financials
    • 16.3.3.4 SWOT Analysis
  • 16.3.4 Bio-Rad Laboratories Inc.
    • 16.3.4.1 Company Overview
    • 16.3.4.2 Product Portfolio
    • 16.3.4.3 Financials
    • 16.3.4.4 SWOT Analysis
  • 16.3.5 Corning Incorporated
    • 16.3.5.1 Company Overview
    • 16.3.5.2 Product Portfolio
    • 16.3.5.3 Financials
    • 16.3.5.4 SWOT Analysis
  • 16.3.6 Merck KGaA
    • 16.3.6.1 Company Overview
    • 16.3.6.2 Product Portfolio
    • 16.3.6.3 Financials
    • 16.3.6.4 SWOT Analysis
  • 16.3.7 Miltenyi Biotec Inc.
    • 16.3.7.1 Company Overview
    • 16.3.7.2 Product Portfolio
  • 16.3.8 PerkinElmer Inc.
    • 16.3.8.1 Company Overview
    • 16.3.8.2 Product Portfolio
    • 16.3.8.3 Financials
    • 16.3.8.4 SWOT Analysis
  • 16.3.9 pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG
    • 16.3.9.1 Company Overview
    • 16.3.9.2 Product Portfolio
  • 16.3.10 Stemcell Technologies Inc.
    • 16.3.10.1 Company Overview
    • 16.3.10.2 Product Portfolio
  • 16.3.11 Terumo Corporation
    • 16.3.11.1 Company Overview
    • 16.3.11.2 Product Portfolio
    • 16.3.11.3 Financials
    • 16.3.11.4 SWOT Analysis
  • 16.3.12 Thermo Fisher Scientific Inc.
    • 16.3.12.1 Company Overview
    • 16.3.12.2 Product Portfolio
    • 16.3.12.3 Financials
    • 16.3.12.4 SWOT Analysis